Back to Top Skip to main content Skip to sub-navigation

DHA, HA leaders discuss MHS Transformation at AHA panel

Military personnel talking at a podium Dr. Terry Adirim (left), acting assistant secretary of Defense for Health Affairs, and Army Lt. Gen. (Dr.) Ronald J. Place, director of the Defense Health Agency, participated at a roundtable April 12 hosted by the American Hospital Association (Lisa Ferdinando, Department of Defense).

Recommended Content:

Electronic Health Record: MHS GENESIS | Military Health System Transformation | Genesis of MHS GENESIS | Coronavirus | COVID-19 Vaccine Toolkit | Readiness Capabilities

Federal health leaders, including the director of the Defense Health Agency and the acting assistant secretary of defense for health affairs, discussed areas for synergy and collaboration between military and civilian health care partners at a virtual roundtable held by the American Hospital Association April 12.

During a federal health update panel, DHA Director Army Lt. Gen. (Dr.) Ronald Place emphasized the importance of smarter data and information sharing in support of the health care mission.

"We often talk about our interest in creating a more integrated health system, not simply within the Department of Defense, but within the broader American health system," he said.

In doing so, the DHA is looking at multiple and different ways to integrate data sharing both from the Military Health System as well as from outpatient physicians' offices, Place explained.

As an example, Place highlighted MHS GENESIS, the new electronic health record (EHR) system being deployed across the MHS, which the Department of Veterans Affairs will also incorporate.

"In support of that, we're also growing our participation in health information exchanges so that we can more easily share clinical information within our network, with the network, and with other hospitals," he said.

Having one centralized MHS database will facilitate the continuum of care for service members, veterans, and their families across different duty locations and after they retire. It will also provide a centralized repository of medical records that can be shared with DOD and civilian facilities and providers for more efficient, standardized care.

"Integrating health care information is an important attribute for a highly mobile population like ours (military), but really the majority of Americans," said Place.

He added that expanding network capacity and increasing military-civilian partnerships are important areas of mutual interest with potential for collaboration. Getting those right would mean making care available to anyone who needs it, said the DHA director.

"I continue to think there is significant opportunity to develop partnerships that contribute to our readiness and strengthen and deepen our community relationships," he said. They're good for readiness, but they're also good for our relationships with communities as well, he added.

Dr. Terry Adirim, acting assistant secretary of Defense for Health Affairs, expanded on MHS GENESIS in a broader discussion on the MHS Transformation efforts amid responding to the COVID-19 pandemic.

"COVID-19 has been a challenge for all of us, including the Department of Defense and military medicine," she said. "We not only have to respond to our beneficiaries within DOD, but we've also provided a response to our fellow Americans."

For example, she highlighted DOD's active engagement in vaccinating.

"Our Defense Health Agency has led our military medical departments in establishing a program and all the policies, and we've administered already over 2.6 million doses of the COVID-19 vaccine" among DOD personnel, she said. "We've also administered several million doses in our support of the FEMA (Federal Emergency Management Agency) mission to vaccinate fellow Americans."

Like the civilian sector, she noted, the DOD community has suffered infection rates and deaths as well as seen an increase in mental health impacts from the pandemic, particularly on children. It has likewise incurred major financial costs due to the need to invest in personal protection equipment, pay for testing, and provide health care.

"Despite all these impacts, the DOD has responded admirably and has maintained a high level of readiness, so I have to give a shoutout to my military colleagues," she added.

Adirim also underscored DHA's impact on the civilian sector under Place's leadership, particularly in establishing a joint registry for COVID-19.

"That's been an invaluable resource for collecting and assessing clinical information for COVID patients, and we've been able to share what we've learned with the civilian community," she said.

She explained how the MHS Transformation is based on a congressional mandate to make changes in the military health structure, most notably to consolidate all DOD military medical treatment facilities (MTFs) under the DHA. And MHS GENESIS, as the sole EHR across DOD, is part of the transformation.

With MHS GENESIS, Adirim said, "we're going to see a lot of improvements in our ability to standardize care, to facilitate care, implement best practices, provide our clinicians with support in their decision making, etc."

However, "while the COVID pandemic has really stressed the MHS, it has provided opportunities and opened some doors with our EHR," she said. "Like everybody else, we had to singularly focus on COVID, so early in the pandemic we paused a number of these actions to complete the transition, but this winter we were able to resume," she said.

Despite the COVID-19 pandemic, Adirim said she is confident DHA will achieve full implementation of MHS GENESIS across all MTFs by 2023.

"The DHA has already implemented all the policies and procedures that our hospitals and clinics need to follow," she said. "They've been able to standardize the patient experience, standardize care, and be able to achieve some efficiencies."

This is another area for collaboration with civilian partners, she added.

"We're hoping that when we're done with this, we'll be able to share some of those with our civilian-sector colleagues," Adirim said.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA IPM 19-004: Utilization of the Case Management (CM) Registry (Active and Screening) for Military Health System (MHS) Beneficiaries

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s (DHA) procedures to: Outline responsibilities for MHS and Service Department CM personnel to utilize the CM Screening Registry; Identify requirements to utilize CM coding in alignment with current MHS CM coding guidance; and Require the use of standardized Adult and Pediatric Tri-Service Workflow (TSWF) forms for CM documentation (inclusive of telephonic, virtual, or face to face screening) located within AHLTA system and future Electronic Health Record MHS GENESIS

DHA-PI 6025.32: MHS GENESIS Medical Device

Policy

This DHA-PI establishes Defense Health Agency’s (DHA) procedures to provide key stakeholders’ responsibilities for connecting medical devices to MHS GENESIS; establish clinical expectations for connecting medical devices to MHS GENESIS; provide references for MTFs to use in procuring medical devices that will be connected to MHS GENESIS; and provide process for MTFs to elevate medical device connection issues related to MHS GENESIS.

Continuing Implementation of the Reform of the Military Health System

Policy

This memorandum directs the continued implementation of the Military Health System (MHS) organizational reform required by 10 U.S.C. § 1073c, and sections 71 land 712 of the John S. McCain National Defense Authorization Act (NDAA) for Fiscal Year (FY) 2019. The DoD policy for this reform is guided by the goals of improved readiness, better health, better care, and lower cost. The Department will advance these objectives through specific organizational reforms directed by Congress and the continued direction of the Secretary of Defense·anct the National Defense Strategy.

DHA IPM 18-021: Guidance for Immediate Completion and Closure of Open Encounters and Records in Legacy Systems

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) and (e): • Establishes the Defense Health Agency’s (DHA) procedures to complete and close open encounters within the legacy systems in preparation for the implementation of Military Health System (MHS) GENESIS. • Identifies and delineates responsibilities associated with completing and closing open encounters within the legacy systems in preparation for the implementation of MHS GENESIS. • Should be used by DoD military treatment facilities (MTFs) to update procedures and workflows that pertain to the DoD Health Record Management, Patient Administration, and other MTF functions impacted by these decisions. • Is effective immediately; it must be incorporated into a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.

Showing results 1 - 14 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.